Human biology has now entered into a phase of post-genomics and it might not be an exaggeration to say that the major outcome of the human genome sequencing has finally been to open the w… Meer...
Human biology has now entered into a phase of post-genomics and it might not be an exaggeration to say that the major outcome of the human genome sequencing has finally been to open the way to the exploration of the proteome-proteomics. Proteins are the functional output of genes and there are two main expected outcomes from human proteomics. The first is to discover new molecular markers for early diagnosis and profiling of pathologies. The second is to decipher the intracellular signaling pathways leading to the initiation and progression of pathologies, for the identification of new targets and the development of innovative therapeutic strategies. This is clearly a promising challenge that this book explores through a series of ongoing experiences and projects representative of the new era in which biology and medicine have now entered. This volume will be of particular interest to students and professionals engaged in the fields of medicine, biomedical and biopharmaceutical sciences. Bücher > Fremdsprachige Bücher > Englische Bücher 235 x 155 x 22 mm , Springer Netherland, Springer Netherland<
Orellfuessli.ch
Nr. A1014707612. Verzendingskosten:Lieferzeiten außerhalb der Schweiz 3 bis 21 Werktage, , Versandfertig innert 4 - 7 Werktagen, zzgl. Versandkosten. (EUR 18.46) Details...
(*) Uitverkocht betekent dat het boek is momenteel niet beschikbaar op elk van de bijbehorende platforms we zoeken.
[EAN: 9789048166374], Neubuch, [SC: 0.0], [PU: Springer Netherlands], BIOLOGY; GENOME; PROTEIN; PROTEINS; PROTOZOA; SEQUENCING, Druck auf Anfrage Neuware - Human biology has now entered i… Meer...
[EAN: 9789048166374], Neubuch, [SC: 0.0], [PU: Springer Netherlands], BIOLOGY; GENOME; PROTEIN; PROTEINS; PROTOZOA; SEQUENCING, Druck auf Anfrage Neuware - Human biology has now entered into a phase of post-genomics and it might not be an exaggeration to say that the major outcome of the human genome sequencing has finally been to open the way to the exploration of the proteome-proteomics.Proteins are the functional output of genes and there are two main expected outcomes from human proteomics. The first is to discover new molecular markers for early diagnosis and profiling of pathologies. The second is to decipher the intracellular signaling pathways leading to the initiation and progression of pathologies, for the identification of new targets and the development of innovative therapeutic strategies. This is clearly a promising challenge that this book explores through a series of ongoing experiences and projects representative of the new era in which biology and medicine have now entered. 412 pp. Englisch, Books<
Human biology has now entered into a phase of post-genomics and it might not be an exaggeration to say that the major outcome of the human genome sequencing has finally been to open the w… Meer...
Human biology has now entered into a phase of post-genomics and it might not be an exaggeration to say that the major outcome of the human genome sequencing has finally been to open the way to the exploration of the proteome-proteomics.Proteins are the functional output of genes and there are two main expected outcomes from human proteomics. The first is to discover new molecular markers for early diagnosis and profiling of pathologies. The second is to decipher the intracellular signaling pathways leading to the initiation and progression of pathologies, for the identification of new targets and the development of innovative therapeutic strategies. This is clearly a promising challenge that this book explores through a series of ongoing experiences and projects representative of the new era in which biology and medicine have now entered. Bücher / Naturwissenschaften, Medizin, Informatik & Technik / Medizin / Nichtklinische Fächer<
Dodax.de
Nr. 57bc9a8e5a87230916f6c700 Verzendingskosten:Versandkosten: 0.0 EUR, Lieferzeit: 7 Tage, DE. (EUR 0.00) Details...
(*) Uitverkocht betekent dat het boek is momenteel niet beschikbaar op elk van de bijbehorende platforms we zoeken.
Human biology has now entered into a phase of post-genomics and it might not be an exaggeration to say that the major outcome of the human genome sequencing has finally been to open the w… Meer...
Human biology has now entered into a phase of post-genomics and it might not be an exaggeration to say that the major outcome of the human genome sequencing has finally been to open the way to the exploration of the proteome-proteomics. Proteins are the functional output of genes and there are two main expected outcomes from human proteomics. The first is to discover new molecular markers for early diagnosis and profiling of pathologies. The second is to decipher the intracellular signaling pathways leading to the initiation and progression of pathologies, for the identification of new targets and the development of innovative therapeutic strategies. This is clearly a promising challenge that this book explores through a series of ongoing experiences and projects representative of the new era in which biology and medicine have now entered. Books > Biomedicine Soft cover, Springer Shop<
Springer.com
new in stock. Verzendingskosten:zzgl. Versandkosten., exclusief verzendingskosten Details...
(*) Uitverkocht betekent dat het boek is momenteel niet beschikbaar op elk van de bijbehorende platforms we zoeken.
Proteomics: Biomedical and Pharmaceutical Applications ab 168.49 EURO Softcover reprint of the original 1st ed. 2004 Medien > Bücher, Springer Netherlands
eBook.de
Nr. 9048166373. Verzendingskosten:, , DE. (EUR 0.00) Details...
(*) Uitverkocht betekent dat het boek is momenteel niet beschikbaar op elk van de bijbehorende platforms we zoeken.
Human biology has now entered into a phase of post-genomics and it might not be an exaggeration to say that the major outcome of the human genome sequencing has finally been to open the w… Meer...
Human biology has now entered into a phase of post-genomics and it might not be an exaggeration to say that the major outcome of the human genome sequencing has finally been to open the way to the exploration of the proteome-proteomics. Proteins are the functional output of genes and there are two main expected outcomes from human proteomics. The first is to discover new molecular markers for early diagnosis and profiling of pathologies. The second is to decipher the intracellular signaling pathways leading to the initiation and progression of pathologies, for the identification of new targets and the development of innovative therapeutic strategies. This is clearly a promising challenge that this book explores through a series of ongoing experiences and projects representative of the new era in which biology and medicine have now entered. This volume will be of particular interest to students and professionals engaged in the fields of medicine, biomedical and biopharmaceutical sciences. Bücher > Fremdsprachige Bücher > Englische Bücher 235 x 155 x 22 mm , Springer Netherland, Springer Netherland<
Nr. A1014707612. Verzendingskosten:Lieferzeiten außerhalb der Schweiz 3 bis 21 Werktage, , Versandfertig innert 4 - 7 Werktagen, zzgl. Versandkosten. (EUR 18.46)
[EAN: 9789048166374], Neubuch, [SC: 0.0], [PU: Springer Netherlands], BIOLOGY; GENOME; PROTEIN; PROTEINS; PROTOZOA; SEQUENCING, Druck auf Anfrage Neuware - Human biology has now entered i… Meer...
[EAN: 9789048166374], Neubuch, [SC: 0.0], [PU: Springer Netherlands], BIOLOGY; GENOME; PROTEIN; PROTEINS; PROTOZOA; SEQUENCING, Druck auf Anfrage Neuware - Human biology has now entered into a phase of post-genomics and it might not be an exaggeration to say that the major outcome of the human genome sequencing has finally been to open the way to the exploration of the proteome-proteomics.Proteins are the functional output of genes and there are two main expected outcomes from human proteomics. The first is to discover new molecular markers for early diagnosis and profiling of pathologies. The second is to decipher the intracellular signaling pathways leading to the initiation and progression of pathologies, for the identification of new targets and the development of innovative therapeutic strategies. This is clearly a promising challenge that this book explores through a series of ongoing experiences and projects representative of the new era in which biology and medicine have now entered. 412 pp. Englisch, Books<
Human biology has now entered into a phase of post-genomics and it might not be an exaggeration to say that the major outcome of the human genome sequencing has finally been to open the w… Meer...
Human biology has now entered into a phase of post-genomics and it might not be an exaggeration to say that the major outcome of the human genome sequencing has finally been to open the way to the exploration of the proteome-proteomics.Proteins are the functional output of genes and there are two main expected outcomes from human proteomics. The first is to discover new molecular markers for early diagnosis and profiling of pathologies. The second is to decipher the intracellular signaling pathways leading to the initiation and progression of pathologies, for the identification of new targets and the development of innovative therapeutic strategies. This is clearly a promising challenge that this book explores through a series of ongoing experiences and projects representative of the new era in which biology and medicine have now entered. Bücher / Naturwissenschaften, Medizin, Informatik & Technik / Medizin / Nichtklinische Fächer<
- Nr. 57bc9a8e5a87230916f6c700 Verzendingskosten:Versandkosten: 0.0 EUR, Lieferzeit: 7 Tage, DE. (EUR 0.00)
Human biology has now entered into a phase of post-genomics and it might not be an exaggeration to say that the major outcome of the human genome sequencing has finally been to open the w… Meer...
Human biology has now entered into a phase of post-genomics and it might not be an exaggeration to say that the major outcome of the human genome sequencing has finally been to open the way to the exploration of the proteome-proteomics. Proteins are the functional output of genes and there are two main expected outcomes from human proteomics. The first is to discover new molecular markers for early diagnosis and profiling of pathologies. The second is to decipher the intracellular signaling pathways leading to the initiation and progression of pathologies, for the identification of new targets and the development of innovative therapeutic strategies. This is clearly a promising challenge that this book explores through a series of ongoing experiences and projects representative of the new era in which biology and medicine have now entered. Books > Biomedicine Soft cover, Springer Shop<
new in stock. Verzendingskosten:zzgl. Versandkosten., exclusief verzendingskosten
Proteomics: Biomedical and Pharmaceutical Applications ab 168.49 EURO Softcover reprint of the original 1st ed. 2004 Medien > Bücher, Springer Netherlands
- Nr. 9048166373. Verzendingskosten:, , DE. (EUR 0.00)
1Aangezien sommige platformen geen verzendingsvoorwaarden meedelen en deze kunnen afhangen van het land van levering, de aankoopprijs, het gewicht en de grootte van het artikel, een eventueel lidmaatschap van het platform, een rechtstreekse levering door het platform of via een derde aanbieder (Marktplaats), enz., is het mogelijk dat de door euro-boek.nl meegedeelde verzendingskosten niet overeenstemmen met deze van het aanbiedende platform.
Bibliografische gegevens van het best passende boek
Human biology has now entered into a phase of post-genomics and it might not be an exaggeration to say that the major outcome of the human genome sequencing has finally been to open the way to the exploration of the proteome-proteomics.Proteins are the functional output of genes and there are two main expected outcomes from human proteomics. The first is to discover new molecular markers for early diagnosis and profiling of pathologies. The second is to decipher the intracellular signaling pathways leading to the initiation and progression of pathologies, for the identification of new targets and the development of innovative therapeutic strategies. This is clearly a promising challenge that this book explores through a series of ongoing experiences and projects representative of the new era in which biology and medicine have now entered.
Gedetalleerde informatie over het boek. - Proteomics: Biomedical and Pharmaceutical Applications
EAN (ISBN-13): 9789048166374 ISBN (ISBN-10): 9048166373 pocket book Verschijningsjaar: 2010 Uitgever: Springer-Verlag GmbH 408 Bladzijden Gewicht: 0,615 kg Taal: eng/Englisch
Boek bevindt zich in het datenbestand sinds 2011-01-04T06:55:40+01:00 (Amsterdam) Detailpagina laatst gewijzigd op 2022-09-08T11:42:47+02:00 (Amsterdam) ISBN/EAN: 9789048166374
ISBN - alternatieve schrijfwijzen: 90-481-6637-3, 978-90-481-6637-4
Gegevens van de uitgever
Auteur: Hubert Hondermarck Titel: Proteomics: Biomedical and Pharmaceutical Applications Uitgeverij: Springer; Springer Netherland 396 Bladzijden Verschijningsjaar: 2010-12-01 Dordrecht; NL Gedrukt / Gemaakt in Taal: Engels 179,98 € (DE) 185,03 € (AT) 198,50 CHF (CH) POD XII, 396 p.
Proteomics Today, Proteomics Tomorrow.- Proteomic Technologies and Application to the Study of Heart Disease.- Proteomics: Haematological Perspectives.- Proteomics in the Neurosciences.- Ocular Proteomics.- Proteomics in Oncology: the Breast Cancer Experience.- Proteomics of Hepatocellular Carcinoma: Present Status and Future Prospects.- Proteomics and Peptidomics of Gestational Disease.- Applications of Proteomics Technologies for Drug Discovery.- Proteomics and Adverse Drug Reactions.- Proteomics for Development of Immunotherapies.- Role of Proteomics in Medical Microbiology.- The Immunoproteome of H. pylori.- Proteomics of HIV-1 Virion.- Proteomics to Explore Pathogenesis and Drug Resistance Mechanisms in Protozoan Parasites.
Andere boeken die eventueel grote overeenkomsten met dit boek kunnen hebben:
